Camber intros generic QuelicinCamber's generic Quelicin is used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. FDA greenlights Aurobindo’s generic potassium chlorideAurobindo's generic potassium chloride ER tablets will be offered in dosage strengths of 10 mEq, 15 mEq, and 20 mEq. Amneal acquires Kashiv Specialty Pharmaceuticals Through the acquisition of Kashiv Specialty Pharmaceuticals, Amneal has gained a pipeline of 505(b)2 branded products and complex generics. FDA gives tentative nod to Zydus Cadila's generic Truvada Zydus Cadila's generic Truvada obtained the FDA's tentative approval in three dosage strengths. Camber launches generic Lopid Camber's gemfibrozil tablets are available in a dosage strength of 600 mg. Amphastar receives FDA green light for dextrose injection Amphastar has received the FDA's blessing for dextrose injection 50% in the 50-ml Luer-Jet Prefilled Syringe system. Aurobindo intros generic Atripla, gets FDA nod for Arava The company's latest generics offer alternatives for branded drugs indicated for HIV, as well as rheumatoid arthritis. Aurobindo intros generics of Truvada, Minocin The company's latest launches offer generics of a popular HIV and PrEP drug, as well as a common antibiotic. Aurobindo intros generic Gleevec Imatinib mesylate tablets have a market value of roughly $324 million for the 12 months ended January 2021, according to IQVIA. Xiromed launches generic Prilosec Prilosec delayed-release capsules and its generics had a market value of $104.5 million for the 12-month period ended January 2021, according to IQVIA. First Previous 128 129 130 131 132 Next Last
